Search
Search Results
##search.searchResults.foundPlural##
-
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
686PDF: 674Suppl. Files: 91HTML: 177 -
How I treat acute and persistent sickle cell pain
2182PDF: 1212HTML: 807 -
-
Recurrent/Persistent Pneumonia among Children in Upper Egypt
1516PDF: 1436HTML: 518 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
885PDF: 728HTML: 147 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1291PDF: 684Suppl. Files: 156HTML: 554 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4268PDF: 1357HTML: 2131Table 1: 252 -
DIAGNOSTIC ACCURACY OF CLINICAL TOOL ‘STOPS’ AND SERUM PROCALCITONIN FOR OPTIMIZING ANTIBIOTIC THERAPY IN NEONATAL SEPSIS STOPS and procalcitonin for optimizing antibiotics in neonatal sepsis
1959PDF: 695HTML: 517 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3267PDF: 1106HTML: 3255 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRANSFUSION-DEPENDENT β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATIONS Challenges in Supportive Care, Equity, and Compassion at End of Life
1323PDF: 919Html: 218 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2371PDF: 944HTML: 389 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2741PDF: 1848HTML: 742 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM): Implications for Clinical Practice OGTT concordance rate in thalassemia major
877PDF: 650Html: 160 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3089PDF: 1368HTML: 2854Figure 1: 234 -
NURSES’ PHYSICAL AND PSYCHOLOGICAL SYMPTOMS DURING THE FIRST COVID-19 LOCKDOWN IN ITALY A nationwide cross-sectional study in stem cell transplantation setting.
2344PDF: 935HTML: 392 -
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1908PDF: 1033HTML: 277 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3921PDF: 1817HTML: 2784 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1603PDF: 581HTML: 219 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3476PDF: 1989HTML: 3744 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1328PDF: 661HTML: 6943 -
-
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
6009PDF: 1116HTML: 500TABLE: 241FIGURES: 336 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
3218PDF: 1721HTML: 14693Untitled: 279Untitled: 228 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
11216PDF: 6672HTML: 21992 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5692PDF: 3008HTML: 30499Antinori Tables 1,2,3: 433 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
2134PDF: 1133HTML: 502 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
2212PDF: 1394HTML: 11613Figure1: 220Figure 2: 239 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1547PDF: 992HTML: 436 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1790PDF: 829HTML: 1524







